摘要
目的:探讨阿奇霉素序贯疗法用于小儿支原体肺炎患者的疗效。方法:收治小儿支原体肺炎患者112例,随机分为观察组及对照组,各56例。观察组给予阿奇霉素序贯疗法治疗,对照组给予阿奇霉素持续静脉滴注治疗。结果:观察组治疗总有效率高于对照组(P<0.05)。观察组不良反应发生率低于对照组(P<0.05)。结论:阿奇霉素序贯疗法治疗小儿支原体肺炎,显著提升了疗效,且降低了不良反应的发生风险。
Objective:To explore the curative effect of Azithromycin sequential therapy in children with mycoplasma pneumonia.Methods:112 children with mycoplasma pneumonia were selected.They were randomly divided into the observation group and the control group,with 56 cases in each group.The observation group was given Azithromycin sequential therapy,while the control group was given azithromycin continuous intravenous drip.Results:The total effective rate of treatment in the observation group was higher than that of the control group(P<0.05).The incidence of adverse reaction in the observation group was lower than that of the control group(P<0.05).Conclusion:Sequential therapy of azithromycin in the treatment of mycoplasma pneumonia in children can improve the curative effect significantly,and reduced the risk of adverse reaction.
引文
[1]何谭娴.小儿支原体肺炎治疗的研究进展[J].医学综述,2014,20(8):1432-1434.
[2]刘伟,周娟,孙莹,等.阿奇霉素对支气管哮喘患儿外周血辅助性T淋巴细胞9和辅助性T淋巴细胞17功能的影响[J].中华实用儿科临床杂志,2015,9(18):1405-1408.
[3]陈嘉慧,印根权,余嘉璐,等.红霉素与阿奇霉素治疗小儿肺炎支原体肺炎的临床研究[J].中国临床药理学杂志,2015,9(8):587-589.